HRS-5041 Tablets
Sponsors
Jiangsu HengRui Medicine Co., Ltd.
Conditions
Prostate Cancer
Phase 1
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
RecruitingNCT06568094
Start: 2024-09-25End: 2027-06-30Target: 100Updated: 2025-12-31
A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects
CompletedNCT07014488
Start: 2025-06-20End: 2025-08-01Updated: 2025-09-10
A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer
Not yet recruitingNCT07407283
Start: 2026-03-01End: 2028-04-01Target: 100Updated: 2026-02-12